Interleukin-12 primes CD4+ T cells for interferon-γ production and protective immunity during Mycobacterium avium infection

Immunology

Volumn 103, Issue 3, 2001, Pages 368-374

  Silva, Regina A ^a   Flórido, Manuela ^a   Appelberg, Rui ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; IMMUNITY; INFECTION SENSITIVITY; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; FEMALE; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-12; LIVER; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYCOBACTERIUM AVIUM; SPLEEN; TUBERCULOSIS;

EID: 0034943449     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2001.01237.x     Document Type: Article

References (51)

1. Mycobacterial diseases other than tuberculosis
2. Mycobacterial lymphadenitis in children: A prospective study of 105 nontuberculous cases with long-term follow-up
3. Infection with Mycobacterium avium complex in patients without predisposing conditions
4. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome
5. Natural history of disseminated Mycobacterium avium complex infection in AIDS
6. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients
7. Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex
8. Disease due to the Mycobacteriun avium complex in patients with AIDS epidemiology and clinical syndrome
9. Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy
10. Disseminated Mycobacterium avium complex infection: Clinical identification and epidemiologic trends
11. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection
12. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection
13. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection
14. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection
15. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients
16. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guéin and Salmonella enteritidis disseminated infection
17. Interleukin-12: A cytokine at the interface of inflammation and immunity
18. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity
19. IL-12 augments antigen-dependent proliferation of activated T lymphocytes
20. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor)
21. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells
22. Induction of interferon gamma production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers
23. Generation of polarized antigen-specific CD8 effector populations: Reciprocal action of interleukin (IL) -4 and IL-12 in promoting type 2 versus type 1 cytokine profiles
24. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts
25. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines
26. Recombinant interleukin 12 cures mice infected with Leishmania major
27. Development of TH1, CD4+ T cells through IL-12 produced by Listeria-induced macrophages
28. Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from alpha beta TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-gamma production is IFN-gamma-dependent
29. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1) -specific immune responses and inhibits the development of IL-4-producing Th cells
30. Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice
31. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis
32. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection
33. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii
34. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice
35. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis
36. Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection
37. Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type 1 immune response
38. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma
39. Interleukin (IL) -12 deficiency in susceptible mice infected with Mycobacterium avium and amelioration of established infection by IL-12 replacement therapy
40. Evaluation of IL-12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections
41. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major
42. Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes
43. Expression cloning of a protective Leishmania antigen
44. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant
45. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection
46. Antigen specificity of T-cell response to Mycobacterium avium infection in mice
47. IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice
48. Resistance of virulent Mycobacterium avium to interferon-γ-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis
49. Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium
50. + T, cells contributes to the rapid production of IFNγ in response to bacterial pathogens
51. Effects of interleukin-12 in the long-term protection conferred by a Mycobacterium avium sub-unit vaccine